» Articles » PMID: 25620120

Abnormal White Matter Integrity in Antipsychotic-naïve First-episode Psychosis Patients Assessed by a DTI Principal Component Analysis

Abstract

Introduction: Diffusion tensor imaging (DTI) studies in patients with schizophrenia have shown abnormalities in the microstructure of white matter tracts. Specifically, reduced fractional anisotropy (FA) has been described across multiple white matter tracts, in studies that have mainly included patients treated with antipsychotic medications.

Objective: To compare FA in antipsychotic-naïve patients experiencing a first episode of psychosis (FEP) to FA in healthy controls to demonstrate that the variance of FA can be grouped, in a coincidental manner, in four predetermined factors in accordance with a theoretical partition of the white matter tracts, using a principal components analysis (PCA).

Methods: Thirty-five antipsychotic-naïve FEP patients and 35 age- and gender-matched healthy controls underwent DTI at 3T. Analysis was performed using a tract-based spatial statistics (TBSS) method and exploratory PCA.

Results: DTI analysis showed extensive FA reduction in white matter tracts in FEP patients compared with the control group. The PCA grouped the white matter tracts into four factors explaining 66% of the total variance. Comparison of the FA values within each factor highlighted the differences between FEP patients and controls.

Discussion: Our study confirms extensive white matter tracts anomalies in patients with schizophrenia, more specifically, in drug-naïve FEP patients. The results also indicate that a small number of white matter tracts share common FA anomalies that relate to deficit symptoms in FEP patients. Our study adds to a growing body of literature emphasizing the need for treatments targeting white matter function and structure in FEP patients.

Citing Articles

Cortical Network Disruption Is Minimal in Early Stages of Psychosis.

Van Dyken P, Mackinley M, Khan A, Palaniyappan L Schizophr Bull Open. 2024; 5(1):sgae010.

PMID: 39144115 PMC: 11207789. DOI: 10.1093/schizbullopen/sgae010.


The integrity of the corticospinal tract and corpus callosum, and the risk of ALS: univariable and multivariable Mendelian randomization.

Wu J, Zhang G, Zhang L, Ye S, Huang T, Fan D Sci Rep. 2024; 14(1):17216.

PMID: 39060317 PMC: 11282093. DOI: 10.1038/s41598-024-68374-y.


Associations between antipsychotics-induced weight gain and brain networks of impulsivity.

Grosu C, Klauser P, Dwir D, Khadimallah I, Aleman-Gomez Y, Laaboub N Transl Psychiatry. 2024; 14(1):162.

PMID: 38531873 PMC: 10965915. DOI: 10.1038/s41398-024-02881-4.


Interactions between knockout of schizophrenia risk factor Dysbindin-1 and copper metabolism in mice.

Schoonover K, McMeekin L, Farmer C, Varghese N, Queern S, Lapi S Brain Res Bull. 2020; 164:339-349.

PMID: 32795490 PMC: 7554113. DOI: 10.1016/j.brainresbull.2020.07.024.


Effect of DAOA genetic variation on white matter alteration in corpus callosum in patients with first-episode schizophrenia.

Su W, Zhu T, Xu L, Wei Y, Zeng B, Zhang T Brain Imaging Behav. 2020; 15(4):1748-1759.

PMID: 32748316 DOI: 10.1007/s11682-020-00368-6.


References
1.
Friston K, Frith C . Schizophrenia: a disconnection syndrome?. Clin Neurosci. 1995; 3(2):89-97. View

2.
Tandon R, Keshavan M, Nasrallah H . Schizophrenia, "just the facts" what we know in 2008. 2. Epidemiology and etiology. Schizophr Res. 2008; 102(1-3):1-18. DOI: 10.1016/j.schres.2008.04.011. View

3.
Gasparotti R, Valsecchi P, Carletti F, Galluzzo A, Liserre R, Cesana B . Reduced fractional anisotropy of corpus callosum in first-contact, antipsychotic drug-naive patients with schizophrenia. Schizophr Res. 2008; 108(1-3):41-8. DOI: 10.1016/j.schres.2008.11.015. View

4.
Peters B, Karlsgodt K . White matter development in the early stages of psychosis. Schizophr Res. 2014; 161(1):61-9. PMC: 4250450. DOI: 10.1016/j.schres.2014.05.021. View

5.
Chung S, Pelletier D, Sdika M, Lu Y, Berman J, Henry R . Whole brain voxel-wise analysis of single-subject serial DTI by permutation testing. Neuroimage. 2007; 39(4):1693-705. PMC: 2276665. DOI: 10.1016/j.neuroimage.2007.10.039. View